Europe Blood Glucose Monitoring Market - Growth, Trends and Forecast (2020 - 2025)

The market segmented by type (self-monitoring blood glucose and continuous blood glucose monitoring), by component (glucometer devices, test strips, lancets, sensors, and receivers), and by geography.

Market Snapshot

Blood Glucose test Strips

Study Period:

2012-2024

Base Year:

2018

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

  • Europe holds the third-largest market share in the blood glucose monitoring devices market after the Asia Pacific and North America. It is expected to reach approximately USD 3 billion by 2024, growing at a CAGR of 9.9%.
  • Diabetes prevalence is continually increasing, and checking blood glucose levels regularly with glucose monitoring devices is vital for proper diabetes diagnosis and treatment.
  • People who have diabetes (Type-1 and Type-2) can have improved lives by carefully regulating their blood glucose levels. 
  • Owing to the increased patient awareness for glucose monitoring devices, Self-Monitoring Blood Glucose (SMBG) users grew more than 50% in 2013 from the number of users in 2007.

Scope of the Report

The market segmented by type (self-monitoring blood glucose and continuous blood glucose monitoring), by component (glucometer devices, test strips, lancets, sensors, and receivers), and by geography. In the report, Europe segmented into Germany, Spain, Russia, Italy, UK, France and the Rest of Europe.

By Device typeSelf-Monitoring Blood Glucose devicesBy Component

Glucometer Devices

Blood Glucose Test Strips

Lancets

By End-User

Hospital use

Personal use

Continuous Glucose Monitoring devicesBy Component

Sensors

Receivers

By RegionEurope

United Kingdom
Germany
France
Russia
Spain
Italy
Rest of Europe

 
 
 
 
 
 
 
Self-Monitoring Blood Glucose Devices
By Component (Value and Volume, 2012-2024)
Glucometer Devices
Test Strips
Lancets
By End User (Value and Volume, 2012-2024)
Hospital
Glucometer Devices
Test Strips
Lancets
Personal
Glucometer Devices
Test Strips
Lancets
Continuous Blood Glucose Monitoring
By Component (Value and Volume, 2012-2024)
Sensors
Receivers
By Geography
Europe
France (Value and Volume, 2012-2024)
Self-Monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
By End User (Hospital and Home)
By Company (Roche, Abbott, Johnson & Johnson and Others)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
By Company (Dexcom, Abbott, Medtronics and Others)
Germany (Value and Volume, 2012-2024)
Self-Monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
By End User (Hospital and Home)
By Company (Roche, Abbott, Johnson & Johnson and Others)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
By Company (Dexcom, Abbott, Medtronics and Others)
Italy (Value and Volume, 2012-2024)
Self-Monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
By End User (Hospital and Home)
By Company (Roche, Abbott, Johnson & Johnson and Others)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
By Company (Dexcom, Abbott, Medtronics and Others)
Spain (Value and Volume, 2012-2024)
Self-Monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
By End User (Hospital and Home)
By Company (Roche, Abbott, Johnson & Johnson and Others)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
By Company (Dexcom, Abbott, Medtronics and Others)
United Kingdom (Value and Volume, 2012-2024)
Self-Monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
By End User (Hospital and Home)
By Company (Roche, Abbott, Johnson & Johnson and Others)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
By Company (Dexcom, Abbott, Medtronics and Others)
Russia (Value and Volume, 2012-2024)
Self-Monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
By End User (Hospital and Home)
By Company (Roche, Abbott, Johnson & Johnson and Others)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
By Company (Dexcom, Abbott, Medtronics and Others)
Rest of Europe (Value and Volume, 2012-2024)
Self-Monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
By End User (Hospital and Home)
By Company (Roche, Abbott, Johnson & Johnson and Others)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
By Company (Dexcom, Abbott, Medtronics and Others)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Blood Glucose test strips hold the highest market share

  • Glucometer test strips held more than 70% of the market in 2018. Because the glucometer is a one-time purchase, but the test strips are the continuous expense since it is a single-use entity, therefore, test strips impact the patient's costs considerably.
  • Although, the CGM is more advanced patients prefer glucometer because CGM is very expensive as compared to glucometer and cost associated with its consumables.
  • Overall, the demand for the blood glucose test strips is projected to witness significant growth, over the forecast period. The growth of the market studied is expected to be spurred by the rising global diabetic population.
Test Strips by population

To understand key trends, Download Sample Report

Germany holds the highest market share

  • Germany has the highest market share in the European region and is likely to grow with the CAGR of 9% in the forecast period.  In Germany, close to 10% of people suffer from diabetes, in which the type-2 diabetic population accounts for 98%. Blood glucose monitoring is widely used in the developed countries due to high awareness and better reimbursement policies as compared to the developing countries
  • The self-blood glucose monitoring market has the highest sales in Germany, and it accounts for approximately 90% of the market studied.
Test Strips

To understand geography trends, Download Sample Report.

Competitive Landscape

  • The glucometer market is highly fragmented; some of the market players who have high market share are Abbott, Roche, and Johnson and Johnson.
  • The Continous Glucose Monitoring market, on the other hand, is a highly consolidated market, few players hold more than 70% of the market share in the CGM market. Dexcom is the market leader in the CGM market globally.

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-Monitoring Blood Glucose Devices

      1. 5.1.1 By Component (Value and Volume, 2012-2024)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

      2. 5.1.2 By End User (Value and Volume, 2012-2024)

        1. 5.1.2.1 Hospital

          1. 5.1.2.1.1 Glucometer Devices

          2. 5.1.2.1.2 Test Strips

          3. 5.1.2.1.3 Lancets

        2. 5.1.2.2 Personal

          1. 5.1.2.2.1 Glucometer Devices

          2. 5.1.2.2.2 Test Strips

          3. 5.1.2.2.3 Lancets

    2. 5.2 Continuous Blood Glucose Monitoring

      1. 5.2.1 By Component (Value and Volume, 2012-2024)

        1. 5.2.1.1 Sensors

        2. 5.2.1.2 Receivers

    3. 5.3 By Geography

      1. 5.3.1 Europe

        1. 5.3.1.1 France (Value and Volume, 2012-2024)

          1. 5.3.1.1.1 Self-Monitoring Blood Glucose Devices

            1. 5.3.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.1.1.2 By End User (Hospital and Home)

            3. 5.3.1.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)

          2. 5.3.1.1.2 Continuous Glucose Monitoring

            1. 5.3.1.1.2.1 By Component (Sensors and Receivers)

            2. 5.3.1.1.2.2 By Company (Dexcom, Abbott, Medtronics and Others)

        2. 5.3.1.2 Germany (Value and Volume, 2012-2024)

          1. 5.3.1.2.1 Self-Monitoring Blood Glucose Devices

            1. 5.3.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.2.1.2 By End User (Hospital and Home)

            3. 5.3.1.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)

          2. 5.3.1.2.2 Continuous Glucose Monitoring

            1. 5.3.1.2.2.1 By Component (Sensors and Receivers)

            2. 5.3.1.2.2.2 By Company (Dexcom, Abbott, Medtronics and Others)

        3. 5.3.1.3 Italy (Value and Volume, 2012-2024)

          1. 5.3.1.3.1 Self-Monitoring Blood Glucose Devices

            1. 5.3.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.3.1.2 By End User (Hospital and Home)

            3. 5.3.1.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)

          2. 5.3.1.3.2 Continuous Glucose Monitoring

            1. 5.3.1.3.2.1 By Component (Sensors and Receivers)

            2. 5.3.1.3.2.2 By Company (Dexcom, Abbott, Medtronics and Others)

        4. 5.3.1.4 Spain (Value and Volume, 2012-2024)

          1. 5.3.1.4.1 Self-Monitoring Blood Glucose Devices

            1. 5.3.1.4.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.4.1.2 By End User (Hospital and Home)

            3. 5.3.1.4.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)

          2. 5.3.1.4.2 Continuous Glucose Monitoring

            1. 5.3.1.4.2.1 By Component (Sensors and Receivers)

            2. 5.3.1.4.2.2 By Company (Dexcom, Abbott, Medtronics and Others)

        5. 5.3.1.5 United Kingdom (Value and Volume, 2012-2024)

          1. 5.3.1.5.1 Self-Monitoring Blood Glucose Devices

            1. 5.3.1.5.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.5.1.2 By End User (Hospital and Home)

            3. 5.3.1.5.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)

          2. 5.3.1.5.2 Continuous Glucose Monitoring

            1. 5.3.1.5.2.1 By Component (Sensors and Receivers)

            2. 5.3.1.5.2.2 By Company (Dexcom, Abbott, Medtronics and Others)

        6. 5.3.1.6 Russia (Value and Volume, 2012-2024)

          1. 5.3.1.6.1 Self-Monitoring Blood Glucose Devices

            1. 5.3.1.6.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.6.1.2 By End User (Hospital and Home)

            3. 5.3.1.6.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)

          2. 5.3.1.6.2 Continuous Glucose Monitoring

            1. 5.3.1.6.2.1 By Component (Sensors and Receivers)

            2. 5.3.1.6.2.2 By Company (Dexcom, Abbott, Medtronics and Others)

        7. 5.3.1.7 Rest of Europe (Value and Volume, 2012-2024)

          1. 5.3.1.7.1 Self-Monitoring Blood Glucose Devices

            1. 5.3.1.7.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.7.1.2 By End User (Hospital and Home)

            3. 5.3.1.7.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)

          2. 5.3.1.7.2 Continuous Glucose Monitoring

            1. 5.3.1.7.2.1 By Component (Sensors and Receivers)

            2. 5.3.1.7.2.2 By Company (Dexcom, Abbott, Medtronics and Others)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2012-2024)

    2. 6.2 Type-2 Diabetes population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

        1. 7.1.1.1 Overview

        2. 7.1.1.2 Products and Strategies

        3. 7.1.1.3 Financial Benchmarking (Ratio Comparisons with Industry Standards)

        4. 7.1.1.4 Ratio Analysis (5 Years)

        5. 7.1.1.5 Strength and Stability Analysis (5 Years)

        6. 7.1.1.6 Recent Developments

      2. 7.1.2 Roche

        1. 7.1.2.1 Overview

        2. 7.1.2.2 Products and Strategies

        3. 7.1.2.3 Financial Benchmarking (Ratio Comparisons with Industry Standards)

        4. 7.1.2.4 Ratio Analysis (5 Years)

        5. 7.1.2.5 Strength and Stability Analysis (5 Years)

        6. 7.1.2.6 Recent Developments

      3. 7.1.3 Johnson & Johnson

        1. 7.1.3.1 Overview

        2. 7.1.3.2 Products and Strategies

        3. 7.1.3.3 Financial Benchmarking (Ratio Comparisons with Industry Standards)

        4. 7.1.3.4 Ratio Analysis (5 Years)

        5. 7.1.3.5 Strength and Stability Analysis (5 Years)

        6. 7.1.3.6 Recent Developments

      4. 7.1.4 Dexcom

        1. 7.1.4.1 Overview

        2. 7.1.4.2 Products and Strategies

        3. 7.1.4.3 Financial Benchmarking (Ratio Comparisons with Industry Standards)

        4. 7.1.4.4 Ratio Analysis (5 Years)

        5. 7.1.4.5 Strength and Stability Analysis (5 Years)

        6. 7.1.4.6 Recent Developments

      5. 7.1.5 Medtronic

        1. 7.1.5.1 Overview

        2. 7.1.5.2 Products and Strategies

        3. 7.1.5.3 Financial Benchmarking (Ratio Comparisons with Industry Standards)

        4. 7.1.5.4 Ratio Analysis (5 Years)

        5. 7.1.5.5 Strength and Stability Analysis (5 Years)

        6. 7.1.5.6 Recent Developments

      6. 7.1.6 Arkray

        1. 7.1.6.1 Overview

        2. 7.1.6.2 Products and Strategies

        3. 7.1.6.3 Recent Developments

      7. 7.1.7 Ascensia Diabetes Care

        1. 7.1.7.1 Overview

        2. 7.1.7.2 Products and Strategies

        3. 7.1.7.3 Recent Developments

      8. 7.1.8 Agamatrix Inc.

        1. 7.1.8.1 Overview

        2. 7.1.8.2 Products and Strategies

        3. 7.1.8.3 Recent Developments

      9. 7.1.9 Bionime Corporation

        1. 7.1.9.1 Overview

        2. 7.1.9.2 Products and Strategies

        3. 7.1.9.3 Recent Developments

      10. 7.1.10 Acon

        1. 7.1.10.1 Overview

        2. 7.1.10.2 Products and Strategies

        3. 7.1.10.3 Recent Developments

      11. 7.1.11 Medisana

        1. 7.1.11.1 Overview

        2. 7.1.11.2 Products and Strategies

        3. 7.1.11.3 Recent Developments

      12. 7.1.12 Trivida

        1. 7.1.12.1 Overview

        2. 7.1.12.2 Products and Strategies

        3. 7.1.12.3 Recent Developments

      13. 7.1.13 Rossmax

        1. 7.1.13.1 Overview

        2. 7.1.13.2 Products and Strategies

        3. 7.1.13.3 Recent Developments

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Roche

      2. 7.2.2 Johnson & Johnson

      3. 7.2.3 Abbott Diabetes Care

      4. 7.2.4 Dexcom

      5. 7.2.5 Medtronics

      6. 7.2.6 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

Related Reports